$1.29
0.021.57%
Pre-Market: Jul 12, 6:59 PM EDT
15 minutes delayed
RenovoRx
RNXTNASDAQ
RenovoRx (NASDAQ:RNXT) Stock, Analyst Ratings, Price Targets, Forecasts
RenovoRx Inc has a consensus price target of $10.25 based on the ratings of 5 analysts. The high is $16 issued by Roth Capital on November 1, 2021. The low is $4 issued by Alliance Global Partners on February 2, 2024. The 3 most-recent analyst ratings were released by Ascendiant Capital, Alliance Global Partners, and Roth MKM on June 17, 2024, February 2, 2024, and August 18, 2023, respectively. With an average price target of $8.33 between Ascendiant Capital, Alliance Global Partners, and Roth MKM, there's an implied 545.99% upside for RenovoRx Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Ascendiant Capital
Alliance Global Partners
Roth MKM
Roth Capital
1calculated from analyst ratings
Analyst Ratings for RenovoRx
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/17/2024 | Buy Now | 520.16% | Ascendiant Capital | Edward Woo | → $8 | Initiates | → Buy | Get Alert |
| 02/02/2024 | Buy Now | 210.08% | Alliance Global Partners | Scott Henry | → $4 | Initiates | → Buy | Get Alert |
| 11/15/2023 | Buy Now | — | Maxim Group | Jason McCarthy | — | Downgrade | Buy → Hold | Get Alert |
| 08/18/2023 | Buy Now | 907.75% | Roth MKM | Scott Henry | $14 → $13 | Maintains | Buy | Get Alert |
| 11/01/2021 | Buy Now | 1140.31% | Roth Capital | Scott Henry | — | Initiates | → Buy | Get Alert |
| 10/06/2021 | Buy Now | 1062.79% | Maxim Group | Jason McCarthy | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for RenovoRx (RNXT) stock?
The latest price target for RenovoRx (NASDAQ:RNXT) was reported by Ascendiant Capital on June 17, 2024. The analyst firm set a price target for $8.00 expecting RNXT to rise to within 12 months (a possible 520.16% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for RenovoRx (RNXT)?
The latest analyst rating for RenovoRx (NASDAQ:RNXT) was provided by Ascendiant Capital, and RenovoRx initiated their buy rating.
When was the last upgrade for RenovoRx (RNXT)?
There is no last upgrade for RenovoRx
When was the last downgrade for RenovoRx (RNXT)?
The last downgrade for RenovoRx Inc happened on November 15, 2023 when Maxim Group changed their price target from N/A to N/A for RenovoRx Inc.
When is the next analyst rating going to be posted or updated for RenovoRx (RNXT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of RenovoRx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for RenovoRx was filed on June 17, 2024 so you should expect the next rating to be made available sometime around June 17, 2025.
Is the Analyst Rating RenovoRx (RNXT) correct?
While ratings are subjective and will change, the latest RenovoRx (RNXT) rating was a initiated with a price target of $0.00 to $8.00. The current price RenovoRx (RNXT) is trading at is $1.29, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.